Caroline S Dorfman1, Sarah S Arthur1, Gretchen G Kimmick1, Kelly W Westbrook2, Paul Kelly Marcom2, Cheyenne Corbett3, Sara N Edmond4,5, Rebecca A Shelby1. 1. Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC. 2. Division of Medical Oncology, Duke University, Durham, NC. 3. Duke Supportive Care and Survivorship Center, Duke University, Durham, NC. 4. Pain Research, Informatics, Multimorbidity & Education (PRIME) Center, VA Connecticut Healthcare System, West Haven, CT. 5. Department of Psychiatry, Yale School of Medicine, New Haven, CT.
Abstract
OBJECTIVE: Past studies indicate that >90% of breast cancer survivors taking adjuvant endocrine therapy (AET) experience menopausal symptoms including sexual problems (eg, vaginal dryness, dyspareunia); however, research examining the impact of these problems on quality-of-life is limited. This cross-sectional study examined (1) the impact of sexual problems and self-efficacy for coping with sexual problems (sexual self-efficacy) on quality-of-life (ie, psychosocial quality-of-life and sexual satisfaction), and (2) partner status as a moderator of these relationships. METHODS: Postmenopausal breast cancer survivors taking AET completed measures of sexual problems (Menopause-Specific Quality-of-Life [MENQOL] sexual subscale], sexual self-efficacy, psychosocial quality-of-life (MENQOL psychosocial subscale), and sexual satisfaction (Functional Assessment of Cancer Therapy-General item). RESULTS: Bivariate analyses showed that women reporting greater sexual problems and lower sexual self-efficacy had poorer quality-of-life and less sexual satisfaction (all P-values < 0.05). Partner status moderated the relationship between sexual problems and psychosocial quality-of-life (P = 0.02); at high levels of sexual problems, unpartnered women experienced poorer psychosocial quality-of-life than partnered women. Partner status also moderated the relationship between self-efficacy and psychosocial quality-of-life (P = 0.01). Self-efficacy was unrelated to psychosocial quality-of-life for partnered women; for unpartnered women, low self-efficacy was associated with poorer quality-of-life. Partner status did not moderate the relationships between sexual problems or self-efficacy with sexual satisfaction. CONCLUSIONS: Greater sexual problems and lower sexual self-efficacy were associated with poorer psychosocial quality-of-life and sexual satisfaction among postmenopausal breast cancer survivors taking AET. Interventions to address sexual problems and sexual self-efficacy, particularly among unpartnered women, may be beneficial for improving the well-being of postmenopausal breast cancer survivors on AET.
OBJECTIVE: Past studies indicate that >90% of breast cancer survivors taking adjuvant endocrine therapy (AET) experience menopausal symptoms including sexual problems (eg, vaginal dryness, dyspareunia); however, research examining the impact of these problems on quality-of-life is limited. This cross-sectional study examined (1) the impact of sexual problems and self-efficacy for coping with sexual problems (sexual self-efficacy) on quality-of-life (ie, psychosocial quality-of-life and sexual satisfaction), and (2) partner status as a moderator of these relationships. METHODS: Postmenopausal breast cancer survivors taking AET completed measures of sexual problems (Menopause-Specific Quality-of-Life [MENQOL] sexual subscale], sexual self-efficacy, psychosocial quality-of-life (MENQOLpsychosocial subscale), and sexual satisfaction (Functional Assessment of Cancer Therapy-General item). RESULTS: Bivariate analyses showed that women reporting greater sexual problems and lower sexual self-efficacy had poorer quality-of-life and less sexual satisfaction (all P-values < 0.05). Partner status moderated the relationship between sexual problems and psychosocial quality-of-life (P = 0.02); at high levels of sexual problems, unpartnered women experienced poorer psychosocial quality-of-life than partnered women. Partner status also moderated the relationship between self-efficacy and psychosocial quality-of-life (P = 0.01). Self-efficacy was unrelated to psychosocial quality-of-life for partnered women; for unpartnered women, low self-efficacy was associated with poorer quality-of-life. Partner status did not moderate the relationships between sexual problems or self-efficacy with sexual satisfaction. CONCLUSIONS: Greater sexual problems and lower sexual self-efficacy were associated with poorer psychosocial quality-of-life and sexual satisfaction among postmenopausal breast cancer survivors taking AET. Interventions to address sexual problems and sexual self-efficacy, particularly among unpartnered women, may be beneficial for improving the well-being of postmenopausal breast cancer survivors on AET.
Authors: Jeanne Carter; Christina Lacchetti; Barbara L Andersen; Debra L Barton; Sage Bolte; Shari Damast; Michael A Diefenbach; Katherine DuHamel; Judith Florendo; Patricia A Ganz; Shari Goldfarb; Sigrun Hallmeyer; David M Kushner; Julia H Rowland Journal: J Clin Oncol Date: 2017-12-11 Impact factor: 44.544
Authors: Sharon L Bober; Jennifer B Reese; Lisa Barbera; Andrea Bradford; Kristen M Carpenter; Shari Goldfarb; Jeanne Carter Journal: Curr Opin Support Palliat Care Date: 2016-03 Impact factor: 2.302
Authors: Caitlin C Murphy; L Kay Bartholomew; Melissa Y Carpentier; Shirley M Bluethmann; Sally W Vernon Journal: Breast Cancer Res Treat Date: 2012-06-12 Impact factor: 4.872
Authors: J R Hilditch; J Lewis; A Peter; B van Maris; A Ross; E Franssen; G H Guyatt; P G Norton; E Dunn Journal: Maturitas Date: 1996-07 Impact factor: 4.342
Authors: Lynne I Wagner; Fengmin Zhao; Paul E Goss; Judith-Anne W Chapman; Lois E Shepherd; Timothy J Whelan; Bassam I Mattar; Jose A Bufill; William C Schultz; Irving E LaFrancis; Gauri G Nagargoje; Radhakrishna Vemuri; Daniel A Nikcevich; George W Sledge; David Cella Journal: Breast Cancer Res Treat Date: 2018-02-17 Impact factor: 4.872
Authors: Harold J Burstein; Christina Lacchetti; Holly Anderson; Thomas A Buchholz; Nancy E Davidson; Karen E Gelmon; Sharon H Giordano; Clifford A Hudis; Alexander J Solky; Vered Stearns; Eric P Winer; Jennifer J Griggs Journal: J Clin Oncol Date: 2016-02-16 Impact factor: 44.544
Authors: Debra L Barton; Stephanie L Pugh; Patricia A Ganz; Steven C Plaxe; Bridget F Koontz; Jeanne Carter; Natalya Greyz-Yusupov; Seth J Page; Kendrith M Rowland; Ernie P Balcueva; Sobia Nabeel; Jack B Basil; Matthew L Hill; Carolyn Y Muller; Maria C Bell; Snehal Deshmukh; Lisa A Kachnic Journal: J Clin Oncol Date: 2021-12-09 Impact factor: 44.544
Authors: Andrew Ernst; Kathryn E Flynn; Elizabeth M Weil; Bradley H Crotty; Sailaja Kamaraju; Nicole Fergestrom; Joan Neuner Journal: Clin Breast Cancer Date: 2020-07-22 Impact factor: 3.225
Authors: Jane Frankland; Sally Wheelwright; Natalia V Permyakova; David Wright; Nicole Collaço; Lynn Calman; Jane Winter; Deborah Fenlon; Alison Richardson; Peter W Smith; Claire Foster Journal: BMJ Open Date: 2020-11-12 Impact factor: 2.692